|
FOLD | Amicus Therapeutics, Inc. |
|
|
FOLD | Amicus Therapeutics, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.20 |
| Leverage | 75.35% |
| Market Cap | $ 2.9B |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -29.5m |
| Margin | -5.49% |
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing and delivering drugs for people living with rare metabolic diseases. The company is headquartered in Philadelphia, Pennsylvania.